Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis

Digestive Diseases and Sciences

Volumn 61, Issue 10, 2016, Pages 2972-2976

  Cleveland, Noa Krugliak ^a   Rodriquez, Dylan ^a   Wichman, Alana ^a   Pan, Isabella ^a   Melmed, Gil Y ^b   Rubin, David T ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Inflammatory bowel disease; Measles; MMR; Pertussis; Tdap; Vaccination

Indexed keywords

AZATHIOPRINE; INTEGRIN; MEASLES ANTIBODY; MERCAPTOPURINE; METHOTREXATE; BACTERIUM ANTIBODY; IMMUNOSUPPRESSIVE AGENT; MEASLES VACCINE; PERTUSSIS VACCINE; VIRUS ANTIBODY;

ACTIVE IMMUNIZATION; ADULT; AGED; ANTIBODY TITER; ARTICLE; COLITIS; CROHN DISEASE; DISEASE DURATION; FEMALE; HUMAN; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; PERTUSSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; ULCERATIVE COLITIS; BORDETELLA PERTUSSIS; COLITIS, ULCERATIVE; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; MORBILLIVIRUS; PROSPECTIVE STUDY; SECONDARY IMMUNIZATION; UNITED STATES; WHOOPING COUGH; YOUNG ADULT;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; BORDETELLA PERTUSSIS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MALE; MEASLES; MEASLES VACCINE; MIDDLE AGED; MORBILLIVIRUS; PERTUSSIS VACCINE; PROSPECTIVE STUDIES; UNITED STATES; WHOOPING COUGH; YOUNG ADULT;

EID: 84983441105     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-016-4275-2     Document Type: Article

References (20)

1. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517.
2. Long MD, Martin C, Sandler RS, Kappelman MD. Increased risk of pneumonia among patients with inflammatory bowel disease. Am J Gastroenterol. 2013;108:240–248.
3. Tinsley A, Williams E, Liu G, Elwir S, Yoo L, Melmed G, Sands B. The incidence of influenza and influenza-related complications in inflammatory bowel disease patients across the united states. Presented at the 2013 Annual Scientific Meeting of the American College of Gastroenterology. San Diego, CA. 2013; Abstract 70.
4. Measles history. [Web]. 2014; http://www.cdc.gov/measles/about/history.html. Accessed January 1, 2016.
5. Zipprich J, Winter K, Hacker J, Xia D, Watt J, Harriman K. Measles Outbreak–California, December 2014–February 2015. [Web]. 2015; http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6406a5.htm?s_cid=mm6406a5_w. Accessed April 4, 2015.
6. Slade TA, Klekamp BG, Rico E, Mejia-Echeverry A. Measles Outbreak in an Unvaccinated Family and a Possibly Associated International Traveler—Orange County, Florida, December 2012–January 2013. [Web]. 2014; http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6336a1.htm. Accessed April 4, 2015.
7. Pertussis (Whooping Cough) Surveillance and Reporting. [Web]. 2015; http://www.cdc.gov/pertussis/surv-reporting.html. Accessed January 5, 2015.
8. Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of bordetella pertussis to young infants. Pediatr Infect Dis J. 2007;26:293–299.
9. Skoff TH, Kenyon C, Cocoros N, et al. Sources of infant pertussis infection in the united states. Pediatrics. 2015;136:635–641.
10. Sands BE, Cuffari C, Katz J, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:677–692.
11. Dave M, Purohit T, Razonable R, Loftus EV Jr. Opportunistic infections due to inflammatory bowel disease therapy. Inflamm Bowel Dis. 2014;20:196–212.
12. Toruner M, Loftus EV Jr, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008;134:929–936.
13. Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infection and mortality in patients with Crohn’s disease: more than 5 years of follow-up in the treat registry. Am J Gastroenterol. 2012;107:1409–1422.
14. Dezfoli S, Melmed GY. Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression. Gastroenterol Hepatol (N Y). 2012;8:504–512.
15. Melmed GY, Agarwal N, Frenck RW, et al. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol. 2010;105:148–154.
16. Dezfoli S, Horton HA, Thepyasuwan N, et al. Combined immunosuppression impairs immunogenicity to tetanus and pertussis vaccination among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1754–1760.
17. deBruyn J, Fonseca K, Ghosh S, et al. Immunogenicity of influenza vaccine for patients with inflammatory bowel disease on maintenance infliximab therapy: a randomized trial. Inflamm Bowel Dis. 2016;22:638–647.
18. Winthrop KL, Baddley JW, Chen L, et al. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA. 2013;309:887–895.
19. Zhang J, Xie F, Delzell E, et al. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA. 2012;308:43–49.
20. Heijstek MW, Kamphuis S, Armbrust W, et al. Effects of the live attenuated measles–mumps–rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial. JAMA. 2013;309:2449–2456.